| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | 1 | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.48 |
—
—
—
|
| 2025 | 0.44 |
—
—
—
—
|
| 2024 | 0.39 |
—
—
—
—
|
| 2023 | 0.33 |
—
—
—
—
|
| 2022 | 0.32 |
—
—
—
—
|
| 2021 | 0.32 |
—
—
—
—
|
| 2020 | 0.32 |
—
—
—
—
|
| 2019 | 0.32 |
—
—
—
—
|
| 2018 | 0.31 |
—
—
—
—
|
| 2017 | 0.30 |
—
—
—
—
|
| 2016 | 0.28 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 1,927.09 | 672.48 | 639.10 | 499.43 |
| Receivables | 1,970.78 | 2,096.93 | 2,210.39 | 2,582.68 |
| Inventory | 403.71 | 387.60 | 418.77 | 433.62 |
| Other | 297.52 | 249.55 | 254.64 | 340.22 |
| 5,220.03 | 3,406.56 | 3,522.89 | 3,855.93 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 1,271.86 | 1,394.01 | 1,522.75 | 1,139.10 |
| ST’ Debt | 1,543.03 | 964.29 | 31.54 | 34.92 |
| Other | 1,930.00 | — | — | — |
| 5,029.97 | 4,214.21 | 3,546.72 | 3,001.23 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 4,831.55 | 4,907.34 | 5,057.91 | — |
—
|
| ’25 | 4,552.09 | 4,279.30 | 4,626.45 | 5,048.46 |
18,506.30
|
| ’24 | 4,407.77 | 4,199.91 | 4,376.08 | 4,416.95 |
17,400.70
|
| ’23 | 3,913.72 | 3,916.16 | 4,053.05 | 4,200.29 |
16,083.21
|
| ’22 | 3,948.26 | 3,860.53 | 4,127.38 | 1,751.10 |
13,687.27
|
| ’21 | 2,743.79 | 2,819.69 | 2,981.22 | 3,551.26 |
12,095.96
|
| ’20 | 4,253.60 | 3,731.56 | 2,152.25 | 2,692.15 |
12,829.56
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | (782.20) | 400.25 | 117.19 | — |
—
|
| ’25 | (587.15) | 255.95 | 76.68 | 1,175.56 |
921.04
|
| ’24 | (657.08) | 221.28 | 140.70 | 1,021.62 |
726.51
|
| ’23 | (615.75) | 253.31 | (52.57) | 926.65 |
511.65
|
| ’22 | (503.39) | 375.12 | (13.73) | 605.91 |
463.91
|
| ’21 | (115.17) | 337.03 | 11.93 | 423.29 |
657.08
|
| ’20 | (309.48) | 217.86 | 16.78 | 251.53 |
176.68
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | (935.92) | 305.41 | 8.69 | — |
—
|
| ’25 | (704.94) | 141.25 | (33.55) | 1,051.70 |
454.46
|
| ’24 | (768.28) | 140.24 | 62.03 | 889.05 |
323.03
|
| ’23 | (701.30) | 176.27 | (135.60) | 806.81 |
146.17
|
| ’22 | (569.03) | 277.73 | (96.34) | 555.93 |
168.29
|
| ’21 | (180.23) | 259.34 | (89.40) | 292.02 |
281.74
|
| ’20 | (405.03) | 108.08 | (37.26) | 146.47 |
(187.75)
|
| Dec | Mar | Jun | Sep | Year | |
|---|---|---|---|---|---|
| ’26 | 0.36 | 0.38 | 0.36 | — |
—
|
| ’25 | 0.39 | 0.23 | 0.27 | 0.33 |
1.22
|
| ’24 | 0.11 | 0.20 | 0.22 | 0.46 |
0.99
|
| ’23 | 0.28 | 0.21 | 1.29 | 0.78 |
2.57
|
| ’22 | 0.17 | 0.14 | 0.16 | 0.29 |
0.75
|
| ’21 | (0.32) | (0.30) | 0.13 | 0.14 |
(0.36)
|
| ’20 | 0.57 | (0.80) | (1.01) | (0.59) |
(1.83)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 20.75 | 23.55 | 27.47 | 29.92 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.29 | 33.01 | 42.49 | 44.49 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 273,875 | 262,550 | 266,680 | 278,390 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.05 | 0.06 | 0.07 | 0.07 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13,687.27 | 16,083.21 | 17,400.70 | 18,506.30 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 7.83% | 8.14% | 8.19% | 8.36% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.21 | 563.52 | 364.87 | 430.46 | ‡‡‡‡‡ | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.34% | 3.50% | 2.10% | 2.33% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.78 | 447.10 | 261.89 | 326.87 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 397.98 | 409.86 | 435.55 | 476.35 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53.19 | 61.72 | 66.15 | 70.14 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.76 | 2.59 | 1.00 | 1.24 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.80 | 1.96 | 2.76 | 3.49 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.15) | (1.40) | (1.53) | (1.77) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.65 | 0.56 | 1.23 | 1.72 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.77 | 14.25 | 11.55 | 11.93 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 257.31 | 260.59 | 263.05 | 263.86 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 29.64 | 9.66 | 39.12 | 31.22 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.42 | 0.41 | 0.59 | 0.55 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.91 | 1.76 | 3.35 | 3.22 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.94 | 0.70 | 0.85 | 0.81 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.85) | (5.05) | (7.22) | (7.77) | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 463.91 | 511.65 | 726.51 | 921.04 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (295.62) | (365.48) | (403.48) | (466.57) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 168.29 | 146.17 | 323.03 | 454.46 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.10 | 190.06 | (807.65) | (23.83) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,410.91 | 6,641.69 | 5,271.46 | 5,405.94 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,081.46 | 4,714.61 | 4,598.97 | 4,766.84 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,029.64 | 3,712.72 | 3,038.97 | 3,148.06 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.32% | 4.22% | 1.78% | 2.51% | ‡‡‡‡‡ | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.57% | 4.64% | 5.78% | 6.25% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.76% | 20.00% | 7.78% | 10.55% | ‡‡‡‡‡ | — | — |
ROE
|
Aramark (ARMK), the resilient giant in food services, facilities management, and uniforms serving stadiums, schools, and hospitals, is charging through its post-pandemic rebound with impressive momentum. Revenue has surged back from a COVID-induced 21% plunge in 2020 to $17.4 billion in 2024, with analysts forecasting a robust climb to $22.3 billion by 2027—driven by 14% growth in 2025 alone. Efficiency is shining through, with revenue per employee up 34% to $65,249 and gross margins stabilizing at 8.2%, signaling smarter operations and cost controls amid easing inflation.
Profitability and cash flow are the real stars, transforming losses into a projected EPS of $2.66 by 2027 and free cash flow powering debt reduction from $9.3 billion peaks to $5.3 billion today. ROE has rebounded to 20%, insider confidence is booming with the CEO’s recent $250k share purchase, and price targets point to 10-30% upside from current levels. This undervalued compounder, trading at attractive multiples amid steady mid-single-digit growth tailwinds like office returns and sports booms, offers exciting potential for patient investors.
Yet risks like cyclicality and competition linger, but Aramark’s execution—from strategic acquisitions to disciplined capex—positions it for outsized returns. Dive into the full analysis for the charts, forecasts, and why this gritty comeback could supercharge your portfolio.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.